Vadodara News Flash

Continuous Bioprocessing Market: Meticulous Research Reveals Why This Market is Growing at a CAGR of 23.0% to Reach $429.12 Million by 2028

 Breaking News
  • No posts were found

Continuous Bioprocessing Market: Meticulous Research Reveals Why This Market is Growing at a CAGR of 23.0% to Reach $429.12 Million by 2028

September 01
11:13 2021
The continuous bioprocessing market is expected to grow at a CAGR of 23.0% from 2021 to reach $429.12 million by 2028
Continuous Bioprocessing Market by Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography – Forecast to 2028

The benefits of continuous manufacturing are widely discussed across different manufacturing industries. Growing demand for biosimilars and increasing pressure for reducing manufacturing costs are positively driving the adoption of continuous bioprocessing in pharma and biotech manufacturing. Biopharmaceutical manufacturers are adopting continuous bioprocessing to intensify the production of biopharmaceuticals and increase facility output, which, in turn, reduces manufacturing costs.

Active research and development in the area of biopharmaceuticals to COVID-19 also suggests the growing adoption of continuous bioprocessing technologies. Meticulous Research®, in its latest publication on the Continuous Bioprocessing Market, states that the market will increase at a CAGR of 23.0% from 2021 to 2028 to reach $429.12 million by 2028.

To provide efficient analysis, Meticulous Research has segmented this market based on Product (Filtration, Chromatography, Centrifuges, Consumables), Application (Commercial {Vaccines, Monoclonal Antibodies}, R&D), End User (Pharmaceuticals, Biotechnology, CROs), and Geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

Geographically, North America commanded the largest share in this market in 2020, followed by Europe. The major share of North America is mainly attributed to the growing adoption of biosimilars due to cost-saving, established healthcare systems, greater adoption of advanced technologies, growth in pharmaceutical research & development, and key players’ presence.

Download Free Sample Report Copy Here : https://www.meticulousresearch.com/download-sample-report/cp_id=5079

On the basis of product, the filtration systems and consumables segment commanded the largest share of the market in 2020. The growing use of filtration systems across every step in bioprocessing is the key factor driving the market growth. The use of filtration in bioprocessing is among the essential steps and is carried out in conjunction with other unit operations for separation, isolation, and purification of biotherapeutics. Thus, the adoption of filtration systems and consumables is the highest in the manufacturing of vaccines, gene therapy, cell therapy, mAb manufacturing, and recombinant proteins.

Scope of the Report:

Global Continuous Bioprocessing Market, by Product

  • Filtration Systems and Consumables
  • Chromatography Systems and Consumables
  • Bioreactors
  • Sterilizers
  • Centrifuges
  • Incubators and Shakers
  • Mixing Systems
  • Cell Culture Media, Buffers, and Reagents
  • Other instruments and consumables

Global Continuous Bioprocessing Market, by Application

  • Commercial
    • Vaccines
    • mAb production
    • Recombinant Protein Production
    • Cell and Gene Therapy Production
  • R&D

Global Continuous Bioprocessing Market, by End User

  • Pharmaceutical and Biotechnology Companies
  • Contract Development and Manufacturing Organizations and Contract Research Organizations
  • Academic and Research Institutes

Global Continuous Bioprocessing Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • China
    • Japan
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business : https://www.meticulousresearch.com/speak-to-analyst/cp_id=5079

Based on application, the commercial segment accounted for the largest market share in 2020 due to the growing adoption of continuous manufacturing in biopharmaceutical production. In addition, the growing approval of antibodies and therapeutic proteins and expansion by various commercial biopharmaceutical manufacturers to cater to unmet demand for vaccines and other biopharmaceutical products in a short period further drives the growth of this segment.

Based on end user, pharmaceutical & biotechnology companies accounted for the largest share of the overall continuous bioprocessing market in 2020. However, the CDMOs and CMOs segment is slated to grow at the highest CAGR during the forecast period, mainly due to growing trend towards outsourcing biologics manufacturing and favorable regulatory reforms for CMOs.

To gain more insights into the market with a detailed table of content and figures, click here : https://www.meticulousresearch.com/product/continuous-bioprocessing-market-5079

Key Players:

The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players operating in the global continuous bioprocessing market. Some of the major players profiled in this report include 3M (U.S.), Cytiva (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), Sartorius AG (Germany), Repligen Corporation (U.S.), Eppendorf AG (Germany), Applikon Biotechnology (Netherlands), Pall Corporation (U.S.), and Bionet (Spain).

Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here-https://www.meticulousresearch.com/custom-research

About Meticulous Research®

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

Media Contact
Company Name: Meticulous Market Research Pvt Ltd
Contact Person: Khushal Bombe
Email: Send Email
Phone: +1 646-781-8004
Address:1267 Willis St, Ste 200 Redding, California, 96001, U.S.
Country: United States
Website: www.meticulousresearch.com

Related Articles